Tucaliv 150 mg Tablets

Tucaliv 150 mg Tucatinib tablets for metastatic breast cancer treatment

*To be consumed as directed by physician.

Therapies:

Breast Cancer

Composition:

Tucatinib 150 mg

About Tucaliv 150 mg Tablets - Tucatinib for HER2-Positive & Metastatic Cancer

Tucaliv 150 mg Tablets contains Tucatinib 150 mg, a targeted anticancer medicine used for the treatment of HER2-positive advanced or metastatic breast cancer, including cases where cancer has spread to the brain. It is usually prescribed in combination with trastuzumab and capecitabine after previous HER2-directed therapies.

Tucaliv 150 mg Tucatinib tablets for metastatic breast cancer treatment

*To be consumed as directed by physician.


Usage Instructions

  • Take Tucaliv 150 mg Tablets exactly as prescribed by your oncologist.
  • Continue treatment for the full duration recommended by your doctor.
  • Regular medical check-ups and liver function monitoring may be required during therapy.

  • Benefits and Use

  • Tucaliv 150 mg Tablets is used for the treatment of HER2-positive advanced or metastatic breast cancer, including brain metastases.
  • It works by specifically blocking the HER2 protein that promotes cancer cell growth and spread.
  • Tucatinib can cross the blood-brain barrier, helping treat cancer that has spread to the brain.
  • When used with trastuzumab and capecitabine, it helps slow disease progression and improve treatment outcomes.

  • Safety Information

  • Alcohol: Avoid or limit alcohol consumption during treatment, as it may increase the risk of liver-related side effects.
  • Pregnancy: Unsafe during pregnancy. Effective contraception should be used during treatment and for at least 1 week after the last dose.
  • Breastfeeding: Breastfeeding is not recommended during treatment, as the medicine may pass into breast milk and harm the baby.
  • Driving: Use caution while driving or operating machinery, as this medicine may cause dizziness or fatigue in some patients.
  • Liver Disease: Use with caution in patients with liver disorders. Regular liver function tests are recommended during treatment.
  • Kidney Disease: Inform your doctor if you have kidney problems before starting treatment.
  • Lung Conditions: Use under medical supervision if you have lung-related conditions. Report any breathing difficulties or unusual symptoms to your doctor.

  • Ingredients

    Tucatinib 150 mg

    How to Use

  • Take the Tablets by mouth as directed by your doctor, usually twice daily (every 12 hours), with or without food.
  • Swallow the Tablets whole with water.
  • Do not crush, chew, or break it.

  • Storage Information

    Store below 30°C in a cool, dry place away from direct sunlight and moisture.